MGLL-IN-Cpd239

General

Type : Urea derivative, Azetidin

Chemical_Nomenclature : (4aR,8aS)-6-[3-[(4-chloro-2-phenoxyphenyl)methoxy]azetidine-1-carbonyl]-4,4a,5,7,8,8a-hexahydropyrido[4,3-b][1,4]oxazin-3-one

Canonical SMILES : C1CN(CC2C1OCC(=O)N2)C(=O)N3CC(C3)OCC4=C(C=C(C=C4)Cl)OC5=CC=CC=C5

InChI : InChI=1S\/C24H26ClN3O5\/c25-17-7-6-16(22(10-17)33-18-4-2-1-3-5-18)14-31-19-11-28(12-19)24(30)27-9-8-21-20(13-27)26-23(29)15-32-21\/h1-7,10,19-21H,8-9,11-15H2,(H,26,29)\/t20-,21+\/m1\/s1

InChIKey : LDQPCFUWDSJVGK-RTWAWAEBSA-N

Other name(s) : Compound 239  ||  Cpd239  ||  CHEMBL4875383  ||  SCHEMBL21730690  ||  BDBM50569654


MW : 471.9

Formula : C24H26ClN3O5

CAS_number :

PubChem : 146386830

UniChem : LDQPCFUWDSJVGK-RTWAWAEBSA-N

Target

Families : MGLL-IN-Cpd239 ligand of proteins in family
Monoglyceridelipase_lysophospholip

Protein :
human-MGLL

References (1)

Title : Heterocyclic Compounds as Monoacylglycerol Lipase (MAGL) Inhibitors -
Author(s) : Sabnis RW
Ref : ACS Med Chem Lett , 12 :536 , 2021
PubMedID: 33859792
Gene_locus related to this paper: human-MGLL